After providing end of life care to relatives, what care options do family caregivers prefer for themselves?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 05 11 2019
accepted: 05 09 2020
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 11 11 2020
Statut: epublish

Résumé

We examined how caregivers who had cared for a relative at end of life (EoL) wished to be cared for in the event that they experienced advanced dementia or physical disability in the future, and what factors influenced their preferences for EoL care. In this mixed-methods study, 83 participants, recruited from multiple sources in Israel, were interviewed concerning socio-demographic factors, health status, past experience with EoL, preference for extension of life vs. quality of life (QoL), willingness to be dependent on others, and preferences for EoL care. In case of advanced dementia, 58% preferred euthanasia or suicide; around a third chose those for physical disability. Care by family members was the least desired form of care in the advanced dementia scenario, although more desirable than institutional care in the physical disability scenario. QoL was rated as the highest factor impacting preferences for EoL care. Men demonstrated a higher preference than women for extension of life over QoL. Our study points to the need for society to consider solutions to the request of participants to reject the type of EoL experienced by their relatives. Those solutions include investing in improving the quality of life at the end of life, and offering alternatives such as euthanasia, which a large proportion of our participants found ethically and medically appropriate within the current system of care in the event of severe physical disability, and more so in the event of advanced dementia.

Identifiants

pubmed: 32977327
doi: 10.1371/journal.pone.0239423
pii: PONE-D-19-30823
pmc: PMC7518928
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0239423

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Public Health. 2013 Dec;103(12):e30-9
pubmed: 24134377
Psychooncology. 2015 Nov;24(11):1545-51
pubmed: 25920720
Palliat Support Care. 2016 Dec;14(6):686-712
pubmed: 26732508
J Gerontol B Psychol Sci Soc Sci. 2007 Mar;62(2):S135-41
pubmed: 17379683
Am J Geriatr Psychiatry. 2016 Apr;24(4):261-71
pubmed: 26976293
J Palliat Med. 2005 Feb;8(1):69-78
pubmed: 15662175
J Palliat Care. 2013 Spring;29(1):22-8
pubmed: 23614167
Soc Sci Med. 2004 Dec;59(12):2467-77
pubmed: 15474202
PLoS One. 2017 Apr 5;12(4):e0172104
pubmed: 28379955
Oncol Nurs Forum. 2004 Nov 16;31(6):1105-17
pubmed: 15547633
J Clin Oncol. 2007 Feb 10;25(5):555-60
pubmed: 17290065
Palliat Med. 2015 Oct;29(9):842-50
pubmed: 25805740
Gerontologist. 1992 Feb;32(1):89-95
pubmed: 1740261
J Clin Nurs. 2017 Jun;26(11-12):1681-1689
pubmed: 27603557
J Gen Psychol. 1970 Apr;82(2d Half):165-77
pubmed: 4394812
Swiss Med Wkly. 2018 May 16;148:w14628
pubmed: 29767827
J Pain Symptom Manage. 2001 Sep;22(3):727-37
pubmed: 11532586
Am J Hosp Palliat Care. 2018 Jan;35(1):52-59
pubmed: 28273753
J Gerontol A Biol Sci Med Sci. 2018 Apr 17;73(5):695-701
pubmed: 29040427
Isr J Health Policy Res. 2013 Jan 23;2(1):3
pubmed: 23343104
Clin J Am Soc Nephrol. 2010 Feb;5(2):195-204
pubmed: 20089488
J Alzheimers Dis. 2019;69(4):989-1001
pubmed: 31127774
Ann Intern Med. 2010 Aug 17;153(4):256-61
pubmed: 20713793
Am J Geriatr Psychiatry. 2002 Jul-Aug;10(4):365-72
pubmed: 12095896
J Adv Nurs. 2000 Jun;31(6):1416-21
pubmed: 10849154
Acta Psychiatr Scand. 2006 Jun;113(6):492-500
pubmed: 16677226
Lancet. 2017 Jun 24;389(10088):2542-2550
pubmed: 28495114
Soc Sci Med. 1997 Dec;45(11):1715-27
pubmed: 9428090
Przegl Lek. 2012;69(2):49-53
pubmed: 22768413
Death Stud. 2011 Feb;35(2):99-106
pubmed: 24501830
J Med Ethics. 2015 Aug;41(8):611-7
pubmed: 25142806
Int J Geriatr Psychiatry. 2010 Jan;25(1):46-54
pubmed: 19551703
BMJ. 2010 Mar 23;340:c1345
pubmed: 20332506
Am J Bioeth. 2007 Apr;7(4):48-56
pubmed: 17454999
Omega (Westport). 2009-2010;60(3):273-97
pubmed: 20361726
Res Theory Nurs Pract. 2009;23(1):23-41
pubmed: 19418886
CMAJ. 2004 Jun 8;170(12):1795-801
pubmed: 15184333
Psychiatr Serv. 2013 Jun;64(6):586-9
pubmed: 23728601
JAMA. 2000 Nov 15;284(19):2460-8
pubmed: 11074775
Ann Fam Med. 2015 Sep;13(5):421-8
pubmed: 26371262
Support Care Cancer. 2010 Nov;18(11):1445-53
pubmed: 19859745
Camb Q Healthc Ethics. 2010 Jul;19(3):381-94
pubmed: 20507686
BMJ Open. 2016 Jan 18;6(1):e009895
pubmed: 26781505
J Aging Health. 1993 Nov;5(4):497-515
pubmed: 10129468
Intensive Care Med. 2012 Jul;38(7):1126-33
pubmed: 22527070
Ann Intern Med. 2000 May 16;132(10):825-32
pubmed: 10819707
Soc Sci Med. 2004 Jun;58(12):2431-44
pubmed: 15081195
Med Care. 1988 Jul;26(7):724-35
pubmed: 3393032
J Pain Symptom Manage. 2006 Feb;31(2):140-7
pubmed: 16488347
BMC Public Health. 2017 Mar 23;17(1):276
pubmed: 28330465
J Palliat Med. 2003 Jun;6(3):381-90
pubmed: 14509483
Intensive Care Med. 2004 May;30(5):770-84
pubmed: 15098087
J Pain Symptom Manage. 2009 Jul;38(1):75-80
pubmed: 19615630
Cancer Nurs. 2003 Jun;26(3):245-51
pubmed: 12832958
J Healthc Risk Manag. 2013;32(4):35-42
pubmed: 23609975
Am J Geriatr Psychiatry. 2019 May;27(5):463-471
pubmed: 30765289
JAMA. 2005 Jul 20;294(3):359-65
pubmed: 16030281
Palliat Med. 2005 Sep;19(6):492-9
pubmed: 16218162

Auteurs

Jiska Cohen-Mansfield (J)

Minerva Center for Interdisciplinary Study of End of Life, Tel-Aviv University, Tel Aviv, Israel.
Department of Health Promotion, School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
The Herczeg Institute on Aging, Tel-Aviv University, Tel Aviv, Israel.

Shai Brill (S)

Minerva Center for Interdisciplinary Study of End of Life, Tel-Aviv University, Tel Aviv, Israel.
Beit Rivka Medical Center, Petah Tikva, Israel.
Tel-Aviv University, Tel-Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH